tratado_fibro_quistica

Tratado de Fibrosis Quística 253
55. Boat TF, Cheng PW, Iyer RN, Carlson DM,
Polony I. Human respiratory tract secretion.
Mucous glycoproteins of nonpurulent
tracheobronchial secretions, and
sputum of patients with bronchitis and
cystic fibrosis. Arch Biochem Biophys.
1976;177(1):95-104.
56. Fuchs HJ, Borowitz DS, Christiansen DH,
Morris EM, Nash ML, Ramsey BW, et al.
Effect of aerosolized recombinant human
DNase on exacerbations of respiratory
symptoms and on pulmonary function
in patients with cystic fibrosis. The Pulmozyme
Study Group. N Engl J Med.
1994;331(10):637-42.
57. McCoy K, Hamilton S, Johnson C. Effects of
12-week administration of dornase alfa in
patients with advanced cystic fibrosis lung
disease. Pulmozyme Study Group. Chest.
1996;110(4):889-95.
58. Cimmino M, Nardone M, Cavaliere M, Plantulli
A, Sepe A, Esposito V, et al. Dornase alfa as
postoperative therapy in cystic fibrosis sinonasal
disease. Arch Otolaryngol Head Neck
Surg. 2005;131(12):1097-101.
59. Grasemann H, Lax H, Treseler JW, Colin AA.
Dornase alpha and exhaled NO in cystic fibrosis.
Pediatr Pulmonol. 2004;38(5):379-85.
60. Furuya ME, Lezana-Fernández JL, Vargas MH,
Hernández-Sierra JF, Ramírez-Figueroa JL.
Efficacy of human recombinant DNase in pediatric
patients with cystic fibrosis. Arch Med
Res. 2001;32(1):30-4.
61. Robinson TE, Goris ML, Zhu HJ, Chen X, Bhise
P, Sheikh F, et al. Dornase alfa reduces air
trapping in children with mild cystic fibrosis
lung disease: a quantitative analysis. Chest.
2005;128(4):2327-35.
62. Konstan MW, Wagener JS, Pasta DJ, Millar SJ,
Jacobs JR, Yegin A, et al. Clinical use of dornase
alpha is associated with a slower rate of FEV1
decline in cystic fibrosis. Pediatr Pulmonol.
2011;46(6):545-53.
63. Nasr SZ, Kuhns LR, Brown RW, Hurwitz ME,
Sanders GM, Strouse PJ. Use of computerized
tomography and chest x-rays in evaluating
efficacy of aerosolized recombinant human
DNase in cystic fibrosis patients younger
than age 5 years: a preliminary study. Pediatr
Pulmonol. 2001;31(5):377-82.
64. Berge MT, Wiel E, Tiddens HA, Merkus PJ,
Hop WC, de Jongste JC. DNase in stable cystic
fibrosis infants: a pilot study. J Cyst Fibros.
2003;2(4):183-8.
65. Fiel SB, Fuchs HJ, Johnson C, Gonda I, Clark
AR. Comparison of three jet nebulizer aerosol
delivery systems used to administer recombinant
human DNase I to patients with cystic
fibrosis. The Pulmozyme rhDNase Study Group.
Chest. 1995;108(1):153-6.